VnP-16 is a peptide corresponding to residues 270-281 of human vitronectin, which exerts an anti-osteoporotic effect via beta1 and alphavbeta3 integrin signaling. VnP-16 promotes bone formation by accelerating osteoblast differentiation through direct interaction
